levodopa methyl ester

Subscribe to Selected New Research on levodopa methyl ester

20 relevant articles (2 outcomes, 1 trials/studies) found for this Bio-Agent

Description: RN given refers to parent cpd(L)-isomer

Also Known As:

L-dopa methyl ester; dl-dopa methyl ester; dopa methyl ester, (D)-isomer; levodopa methyl ester hydrochloride; levodopa methyl ester hydrochloride, (DL)-isomer; melevodopa; methyl L-dopa

Relationship Network

Bio-Agent Context: Research Results

Organic Chemicals: 40

Amines: 1233

Catecholamines: 5627

Dihydroxyphenylalanine: 1277

Levodopa: 7055

levodopa methyl ester: 20

Amino Acids, Peptides, and Proteins

Amino Acids: 8523

Cyclic Amino Acids: 1

Aromatic Amino Acids: 226

Tyrosine: 5335

Dihydroxyphenylalanine: 1277

Levodopa: 7055

levodopa methyl ester: 20

Phenylalanine: 2108

Dihydroxyphenylalanine: 1277

Levodopa: 7055

levodopa methyl ester: 20

Related Diseases

1.	Parkinson Disease (Parkinson's Disease) 06/01/1991 - "The clinical efficacy of oral levodopa methyl ester solution in reversing afternoon "off" periods in Parkinson's disease." 01/01/1992 - "Intravenous boluses and continuous infusions of L-dopa methyl ester in fluctuating patients with Parkinson's disease." 04/01/1991 - "Subcutaneous and sublingual levodopa methyl ester in Parkinson's disease." 07/01/1987 - "Levodopa methyl ester treatment of Parkinson's disease." 01/01/1984 - "L-Dopa methyl ester--a candidate for chronic systemic delivery of L-Dopa in Parkinson's disease." Get all the results and reference details, order at left...
2.	Melanoma (Melanoma, Malignant) 09/15/1988 - "Compounds 1 and 2 exhibited greater potency and selectivity against malignant melanoma than did the natural product L-DOPA methyl ester." 09/15/1988 - "Compound 2 was active in 6 of 10 melanoma and 0 of 5 nonmelanoma cell lines while both Compound 1 and L-DOPA methyl ester were active in 1 of 10 melanomas and 0 of 5 nonmelanomas" 08/01/1978 - "L-dopa methyl ester has been shown to be an effective antitumor agent against the B-16 melanoma in vivo" 01/01/1996 - "These results show that in vivo Tyr and Phe restriction improves the therapeutic response of a metastatic variant of B16-BL6 (BL6) murine melanoma to adriamycin (ADR) and B16 melanoma to levodopa methyl ester" 05/01/1983 - "These data indicate that adding ascorbate and restricting tyrosine and phenylalanine in combination with levodopa methyl ester therapy may become an important strategy for treating malignant melanoma." Get all the results and reference details, order at left...
3.	Experimental Melanoma 01/01/1996 - "These results show that in vivo Tyr and Phe restriction improves the therapeutic response of a metastatic variant of B16-BL6 (BL6) murine melanoma to adriamycin (ADR) and B16 melanoma to levodopa methyl ester" 05/01/1983 - "Sodium ascorbate enhancement of carbidopa-levodopa methyl ester antitumor activity against pigmented B16 melanoma." 08/01/1982 - "Dietary influence of tyrosine and phenylalanine on the response of B16 melanoma to carbidopa-levodopa methyl ester chemotherapy." Get all the results and reference details, order at left...
4.	Dyskinesias (Dyskinesia) 08/01/1987 - "Complex motor fluctuations and dyskinesias ("on-off" phenomenon) in Parkinson's disease can be corrected by parenteral administration of levodopa, levodopa-methyl-ester, lisuride and apomorphine" Get all the results and reference details, order at left...
5.	Parkinsonian Disorders (Parkinsonism) 05/01/1996 - "Fluctuating parkinsonism: a pilot study of single afternoon dose of levodopa methyl ester." Get all the results and reference details, order at left...
12 Diseases and 20 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	madopar
2.	Levodopa (L Dopa)
3.	Sinemet (Nakom)
4.	levodopa methyl ester
5.	Carbidopa (Lodosyn)
6.	alpha-Methyltyrosine (Metirosine)
7.	Tyrosine (L-Tyrosine)
8.	Phenylalanine (L-Phenylalanine)
9.	Norepinephrine (Noradrenaline)
10.	Lisuride
15 Drugs and Important Bio-Agents and 12 more articles analyzed in the Research Interface, order at left...

Related Therapies and Procedures

1.	Drug Therapy (Chemotherapy)
2.	Aftercare (After-Treatment)
2 Therapies and Procedures and 2 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>